Authors |
Min-Zhi Jiang1#, Sheila M. Gaynor2,3#, Xihao Li1,2,4, Eric Van Buren2, Adrienne Stilp5, Erin
Buth5, Fei Fei Wang5, Regina Manansala6, Stephanie M. Gogarten5, Zilin Li7, Linda M.
Polfus8, Shabnam Salimi9, Joshua C. Bis10, Nathan Pankratz11, Lisa R. Yanek12, Peter
Durda13, Russell P. Tracy13, Stephen S. Rich14, Jerome I. Rotter15, Braxton D. Mitchell16,
Joshua P. Lewis16, Bruce M. Psaty10,17, Katherine A. Pratte18, Edwin K. Silverman19,
Robert C. Kaplan20, Christy Avery21, Kari North21, Rasika A. Mathias22, Nauder
Faraday23, Honghuang Lin24, Biqi Wang24, April P. Carson25, Arnita F. Norwood25,
Richard A. Gibbs26, Charles Kooperberg27, Jessica Lundin27, Ulrike Peters27, Josee
Dupuis28, Lifang Hou29, Myriam Fornage30, Emelia J. Benjamin31,32,33, Alexander P.
Reiner34, Russell P. Bowler18, Xihong Lin2, Paul L. Auer35*, Laura M. Raffield1*, NHLBI
Trans-Omics for Precision Medicine (TOPMed) Consortium, TOPMed Inflammation
Working Group
|